chr7-50470140-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The ENST00000444124.7(DDC):c.1073G>A(p.Arg358His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R358C) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000444124.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDC | NM_001082971.2 | c.1073G>A | p.Arg358His | missense_variant | 12/15 | ENST00000444124.7 | NP_001076440.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDC | ENST00000444124.7 | c.1073G>A | p.Arg358His | missense_variant | 12/15 | 1 | NM_001082971.2 | ENSP00000403644 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251392Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135876
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461044Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726912
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Deficiency of aromatic-L-amino-acid decarboxylase Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2022 | Experimental studies have shown that this missense change affects DDC function (PMID: 29356298). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DDC protein function. ClinVar contains an entry for this variant (Variation ID: 379626). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 358 of the DDC protein (p.Arg358His). This variant is present in population databases (rs771317809, gnomAD 0.003%). This missense change has been observed in individual(s) with DDC-related conditions (PMID: 17240182, 32369189). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Oct 17, 2016 | The NM_001082971.1(DDC):c.1073G>A in exon 12 of the DDC gene is predicted to create a change of an arginine to an histidine at amino acid position 358, NP_001076440.1(DDC):p.p.(Arg358His), which is considered not significant. The arginine at this position has very highly conservation but however, Grantham assessment (A-GVGD) is unlikely pathogenic. In silico software predicts this variant to be disease causing. It is situated in a Pyridoxal phosphate-dependent decarboxylase conserved domain. This variant has not been previously observed in our cohort but is present in a population database at a frequency of 0.002%. It has been previously reported in compound heterozygous state in a patient with aromatic -L-amino decarboxylase deficiency (AADC) and functional studies showed reduced enzyme activity (Verbeek MM. et al.,2007). Based on current information, and in association with the NM_001082971.1(DDC):c.1352G>T variant, this variant has been classified as LIKELY PATHOGENIC. The presence of these two variants suggests a possible compound heterozygous mode of inheritance which is consistent with AADC. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 14, 2015 | The R358H variant in the DDC gene has been reported previously in association with AADC deficiency,in an affected individual who was compound heterozygous for the R358H variant and another loss offunction variant. This individual's plasma AADC activity was significantly reduced as compared tonormal AADC activity (Verbeek et al., 2007). The R358H substitution was not observed in approximately6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project,indicating it is not a common benign variant in these populations. The R358H variant is a conservativechange at a position that is conserved across species. In silico analysis predicts this variant is probablydamaging to the protein structure/function. A missense variant in a nearby residue (R347Q) has beenreported in the Human Gene Mutation Database in association with AADC deficiency (Stenson et al.,2014), supporting the functional importance of this region of the protein. We interpret R358H as a pathogenic variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at